Sensei Biotherapeutics Ownership | Who Owns Sensei Biotherapeutics?
Sensei Biotherapeutics Ownership Summary
Sensei Biotherapeutics is owned by 2.95% institutional investors, 34.21% insiders, and 62.84% retail investors. Susquehanna group, llp is the largest institutional shareholder, holding 0.15% of SNSE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.93% of its assets in Sensei Biotherapeutics shares.
SNSE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Sensei Biotherapeutics | 2.95% | 34.21% | 62.84% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Susquehanna group, llp | 38.05K | 0.15% | $18.65K |
| Citadel advisors | 15.37K | 0.06% | $9.53K |
| Raymond james & associates | 14.00K | 0.06% | $8.68K |
| Morgan stanley | 12.22K | 0.05% | $7.58K |
| Blackrock | 7.78K | 0.03% | $4.82K |
| Tower research capital llc (trc) | 5.45K | 0.02% | $2.67K |
| Bank of america corp /de/ | 139.00 | 0.00% | $86.00 |
| Bnp paribas arbitrage, snc | 160.00 | 0.00% | $78.00 |
| Two sigma securities | - | - | - |
| Renaissance | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tower research capital llc (trc) | 5.45K | 0.00% | $2.67K |
| Renaissance | - | - | - |
| Blackrock | 7.78K | - | $4.82K |
| Two sigma advisers, lp | - | - | - |
| National bank of canada /fi/ | - | - | - |
| Two sigma securities | - | - | - |
| Barclays | - | - | - |
| Susquehanna group, llp | 38.05K | - | $18.65K |
| Bank of america corp /de/ | 139.00 | - | $86.00 |
| Geode capital management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bnp paribas arbitrage, snc | 160.00 | - | 160.00 |
| Morgan stanley | 12.22K | - | - |
| Raymond james & associates | 14.00K | - | - |
| Qube research | - | - | -4.00 |
| Citigroup | - | - | -124.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Newtyn management | - | - | -930.23K |
| Vanguard group | - | - | -585.58K |
| Ikarian capital | - | - | -449.96K |
| Renaissance | - | - | -177.30K |
| Geode capital management | - | - | -150.71K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bnp paribas arbitrage, snc | 160.00 | - | 160.00 | $78.00 |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -4.00 |
| Citigroup | -124.00 |
| Wells fargo & company/mn | -133.00 |
| Jpmorgan chase | -702.00 |
| Barclays | -2.56K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 2 | -91.67% | 744,337 | -68.52% | 2 | 3.34% | - | -100.00% | 1 | -90.91% |
| Dec 31, 2024 | 23 | 21.05% | 2,347,616 | 6.38% | 9 | 12.08% | 7 | 40.00% | 11 | 120.00% |
| Sep 30, 2024 | 19 | -17.39% | 2,206,817 | 4.71% | 8 | 12.42% | 5 | -50.00% | 5 | - |
| Jun 30, 2024 | 23 | -4.17% | 2,107,576 | -8.74% | 8 | 12.33% | 10 | 66.67% | 5 | -16.67% |
| Mar 31, 2024 | 24 | 4.35% | 2,309,379 | -22.04% | 8 | 6.13% | 6 | 20.00% | 6 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 485.96K | 1.93% | - |
| Vanguard Total Stock Mkt Idx Inv | 24.11K | 1.91% | -188.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 4.98K | 0.40% | -1.00 |
| Fidelity Extended Market Index | 4.63K | 0.37% | -1.00 |
| Bridgeway Ultra-Small Company Market | 47.90K | 0.19% | - |
| Fidelity Series Total Market Index | 1.66K | 0.13% | -1.00 |
| Fidelity Total Market Index | 1.42K | 0.11% | - |
| Northern Trust Extended Eq Market Idx | 895.00 | 0.07% | -1.00 |
| NT Ext Equity Mkt Idx Fd - L | 895.00 | 0.07% | -1.00 |
| Vanguard Instl Ttl Stck Mkt Idx Tr | 15.07K | 0.06% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2023 | Celebi John | President and CEO | Buy | $425.00 |
| Jun 01, 2023 | Apeiron Investment Group Ltd. | - | Sell | $1.51M |
| Feb 23, 2023 | Apeiron Investment Group Ltd. | - | Buy | $1.76K |
| Feb 23, 2023 | Apeiron Investment Group Ltd. | - | Buy | $1.78K |
| Mar 02, 2022 | Peyer James | Buy | $3.85K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
SNSE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools